39986-86-2

Usage

Uses

Used in Pharmaceutical Industry:
p-Hydroxy-5,6-dehydrokawain is used as a potential anxiolytic agent for its anti-anxiety properties, offering an alternative for the treatment of anxiety disorders.
p-Hydroxy-5,6-dehydrokawain is used as a sedative agent due to its calming effects, which may be beneficial in managing conditions characterized by restlessness or insomnia.
Used in Neurodegenerative Disease Treatment:
p-Hydroxy-5,6-dehydrokawain is used as a neuroprotective agent for its potential to protect neurons from damage, which could be crucial in the management of neurodegenerative diseases.
Used in Anti-Inflammatory Applications:
p-Hydroxy-5,6-dehydrokawain is used as an anti-inflammatory agent, leveraging its ability to reduce inflammation, which may be beneficial in various inflammatory conditions.

Upstream product

• 123-11-5 4-methoxy-benzaldehyde 
• 500-62-9 yangonin 
• 117081-50-2 5,6-dihydro-6-ethenyl-4-hydroxy-2H-pyran-2-one 
• 1334928-11-8 4-methoxy-6-vinyl-2H-pyran-2-one 
• 771-03-9 3-acetyl-4-hydroxy-6-methyl-2H-pyran-2-one 
• 56070-85-0 4-methoxy-2-oxo-2H-pyran-6-carboxaldehyde 
• 1092383-57-7 4-methoxy-6-vinyl-5,6-dihydro-2H-pyran-2-one 
• 672-89-9 4-methoxy-6-methyl-2H-pyran-2-one 
• 675-10-5 4-hydroxy-6-methyl-2-pyron 

Relevant academic research and scientific papers

The Chemical Basis of Fungal Bioluminescence

Many species of fungi naturally produce light, a phenomenon known as bioluminescence, however, the fungal substrates used in the chemical reactions that produce light have not been reported. We identified the fungal compound luciferin 3-hydroxyhispidin, which is biosynthesized by oxidation of the precursor hispidin, a known fungal and plant secondary metabolite. The fungal luciferin does not share structural similarity with the other eight known luciferins. Furthermore, it was shown that 3-hydroxyhispidin leads to bioluminescence in extracts from four diverse genera of luminous fungi, thus suggesting a common biochemical mechanism for fungal bioluminescence.

Heck-matsuda arylation as a strategy to access kavalactones isolated from polygala sabulosa, piper methysticum, and analogues

Herein, we describe the total syntheses of three bioactive pyrones isolated from Polygala sabulosa (i.e., 1, 4, and 7) and eight isolated from Piper methysticum (i.e., 8-10, 13, 15, and 18-20) using the Heck-Matsuda arylation as the key strategy. The evaluation of this methodology by employing different arenediazonium tetrafluoroborates revealed that the Heck arylation was more efficient when the olefin undergoing arylation possessed the vinyl-2-pyrone structural unit instead of the vinyl dihydro-2-pyrone moiety. The Heck-Matsuda arylation of many of the examined olefins proceeded in a practical manner with total regio- and stereocontrol.